• Busch, M.P. (1998) Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing. Vox Sanguinis, 74, 147154.
  • Busch, M.P. (2000) HIV, HBV and HCV: New developments related to transfusion safety. Vox Sanguinis, 78, 253256.
  • Busch, M.P., Lee, L.L., Satten, G.A., Henrard, D.R., Farzadegan, H., Nelson, K.E., Read, S., Dodd, R.Y. & Petersen, L.R. (1995) Time course of detection of viral and serological markers preceding human immunodeficiency virus type I seroconversion: implications for screening of blood and tissue donors. Transfusion, 35, 9197.
  • Busch, M.P., Kleinman, S.H., Jackson, B., Stramer, S.L., Hewlett, I. & Preston, S. (2000) Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion, 40, 143159.
  • Couroucé, A.M. & Pillonel, J. (1996) Transfusion-Transmitted Viral Infection [letter]. New England Journal of Medicine, 335, 16091610.
  • Couroucé, A.M., Le Marrec, N., Girault, A., Ducamp, S. & Simon, N. (1994) Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assay. Transfusion, 34, 790795.
  • D'Amelio, R., Stroffolini, T., Nisini, R., Matricardi, P.M., Rapicetta, M. & Spada, E. (1994) Incidence of hepatitis B virus infection among an Italian military population: Evidence of low infection spread. European Journal of Epidemiology, 10, 105107.
  • Doebbeling, B.N., Stanley, G.L., Sheetz, C.T., Pfaller, M.A., Houston, A.K., Annis, L., Li, N. & Wenzel, R.P. (1992) Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. New England Journal of Medicine, 327, 8893.
  • Ghirardini, A., Gonzales, M. & Panei, P. (2000) Il sistema di sorveglianza dello screening per HIV nelle donazioni di sangue in Italia. Notiziario dell'Istituto Superiore di Sanità, 13, 1 (January).
  • Glynn, S.A., Kleinman, S.H., Schreiber, G.B., Busch, M.P., Wright, D.J., Smith, J.W., Nass, C.C. & Williams, A.E. for the Retrovirus Epidemiology Donor Study (REDS) (2000) Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Journal of the American Medical Association, 284, 229235.
  • Guadagnino, V., Stroffolini, T., Rapicetta, M., Costantino, A., Kondili, L.A., Menniti-Ippolito, F., Caroleo, B., Costa, C., Griffo, G., Loiacono, L., Pisani, V., Foca, A. & Piazza, M. (1997) Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology, 26, 10061011.
  • Gunson, H.H. & Rawlinson, V.I. (1988) HIV antibody screening of blood donations in the United Kingdom. Vox Sanguinis, 54, 3438.
  • Hoofnagle, J.H., Seeff, L.B., Buskell Bales, Z., Gerety, R.J. & Tabor, E. (1978) Serologic responses in HBV. In: Viral Hepatitis: a Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention (ed. by G.N.Vyas, S.N.Cohen & R.Schmid), pp. 219242. Franklin Institute Press, Philadelphia.
  • Kondili, L.A., Chionne, P., Costantino, A., Villano, U., Lo Noce, C., Pannozzo, F., Mele, A., Gianpaoli, S. & Rapicetta, M. (2001) Infection rate and spontaneous seroreversion of anti-HCV during the natural course of HCV infection in the general population. Gut, in press .
  • Lackritz, E.M., Satten, G.A., Aberle-Grasse, J., Dodd, R.Y., Raimondi, V.P., Janssen, R.S., Lewis, F., Notari, E.P. & Petersen, L.R. (1995) Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. New England Journal of Medicine, 333, 17211725.
  • McCullough, J. (1993) The nation's changing blood supply system. Journal of the American Medical Association, 269, 22392245.
  • Manns, A., Wilks, R.J., Murphy, E.L., Haynes, G., Figueroa, J.P., Barnett, M., Hanchard, B. & Blattner, W.A. (1992) A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. International Journal of Cancer, 51, 886891.
  • Mele, A., Stroffolini, T., Catapano, R., Palumbo, F., Moiraghi, A. & Novaco, F. (1995) Incidence of transfusion associated B and non-A, non-B hepatitis in Italy. British Medical Journal, 311, 846847.
  • Mele, A., Tosti, M.E., Marzolini, A., Moiraghi, A., Ragni, P., Gallo, G., Balocchini, E., Santonastasi, F. & Stroffolini, T. and the SEIEVA Collaborating Group (2000) Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. Journal of Viral Hepatitis, 7, 3035.
  • Mele, A., Spada, E., Sagliocca, L., Ragni, P., Tosti, M.E., Gallo, G., Moiraghi, A., Balocchini, E., Sangalli, M., Lopalco, P.L. & Stroffolini, T. (2001) Risk of parenteral transmitted hepatitis following exposure to surgery and medical invasive procedures. Journal of Hepatology, 35, 284289.
  • Mimms, L.T., Mosley, J.W., Hollinger, F.B., Aach, R.D., Stevens, C.E., Cunningham, M., Vallari, D.V., Barbosa, L.H. & Nemo, G.J. (1993) Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. British Medical Journal, 307, 10951097.
  • Prati, D., Capelli, C., Silvani, C., De Mattei, C., Bosoni, P., Pappalettera, M., Mozzi, F., Colombo, M., Zanella, A. & Sirchia, G. (1997) The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian Blood donors. Hepatology, 25, 702704.
  • Prati, D., Zanella, A., Farma, E., De Mattei, C., Bosoni, P., Zappa, M., Picone, A., Mozzi, F., Rebulla, P., Cappellini, M.D., Allain, J.P. & Sirchia, G. for the Cooleycare Cooperative Group (1998a) A multicenter prospective study on the risk of acquiring liver disease in anti-HCV negative patients affected from homozygous b-thalassemia. Blood, 92, 34603464.
  • Prati, D., Capelli, C., Rebulla, P., Mozzi, F., Bosoni, P., De Mattei, C. & Sirchia, G. (1998b) The current risk of retroviral infections transmitted by transfusion in patients who have undergone multiple transfusions. Cooleycare Cooperative Group. Archives of Internal Medicine, 158, 15661569.
  • Regan, F.A.M., Hewitt, P., Barbara, J.A.J. & Contreras, M. (2000) Prospective investigation on transfusion transmitted infection in recipients of over 20 000 units of blood. British Medical Journal, 320, 403406.
  • Schreiber, G.B., Busch, M.P., Kleiman, S.H. & Korelitz, J.J. for the Retrovirus Epidemiology Donor Study (1996) The risk of transfusion-transmitted viral infection. New England Journal of Medicine, 334, 16851690.
  • Stroffolini, T., Mele, A., Tosti, M.E., Gallo, G., Balocchini, E., Ragni, P., Santonastasi, F., Marzolini, A., Ciccozzi, M. & Moiraghi, A. (2000) The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. Journal of Hepatology, 33, 980985.